Company intelligence / Profile preview

Humanscan

Ownership: Private
Development stage: Other

Overview

Humanscan Co. Ltd develops and applies Acoustic Cluster Therapy, a drug delivery technology designed to enhance the targeting of therapies—particularly for cancer—by driving drugs directly to tumor cells[2]. Detailed clinical results are not provided in the available sources.

Therapeutic areas: Oncology
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Humanscan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Humanscan.

Explore the full profile